COMPANY

For-Robin, Inc.

HQ: Williamsville, NY source · for-robin.com ↗ · Mid-Atlantic

For-Robin is also developing hJAA-F11 for adjunct therapy of breast and lung cancer either directly or as antibody-drug conjugates. From company website Source · Oct 13, 2026

Keywords: antibody-drug conjugates

Location: Williamsville, NY · source · Oct 15, 2026

Profile checked Oct 10, 2026

5NIH grants

NIH awards 5

Annual award amounts. Total $2.7M.

Mar 13, 2019 NIH award 1R43CA236023-01A1 FY2019: $304,318 awarded for that fiscal year; activity R43 (SBIR); PI RITTENHOUSE-OLSON, KATE W; recipient as written: FOR-ROBIN, WILLIAMSVILLE, NY. JAA-F11 Anti-Thomsen-Friedenreich Anti source ↗
Apr 14, 2016 NIH award 5R42CA176951-03 FY2016: $1,013,625 awarded for that fiscal year; activity R42 (STTR); PI RITTENHOUSE-OLSON, KATE W; recipient as written: FOR-ROBIN, WILLIAMSVILLE, NY. Clinical Translation of an Anti-Metast source ↗
Mar 27, 2015 NIH award 2R42CA176951-02A1 FY2015: $973,366 awarded for that fiscal year; activity R42 (STTR); PI RITTENHOUSE-OLSON, KATE W; recipient as written: FOR-ROBIN, WILLIAMSVILLE, NY. Clinical Translation of an Anti-Metast source ↗
Aug 8, 2014 NIH award 3R41CA176951-01S1 FY2014: $128,831 awarded for that fiscal year; activity R41 (STTR); PI RITTENHOUSE-OLSON, KATE W; recipient as written: FOR-ROBIN, WILLIAMSVILLE, NY. Clinical Translation of an Anti-Metast source ↗
Jun 24, 2013 NIH award 1R41CA176951-01 FY2013: $282,224 awarded for that fiscal year; activity R41 (STTR); PI RITTENHOUSE-OLSON, KATE W; recipient as written: FOR-ROBIN, WILLIAMSVILLE, NY. Clinical Translation of an Anti-Metastat source ↗